Tower Research Capital LLC (Trc) G1 Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $5,742 - $12,997	2,610 Added 63.6%	6,714 $15,000
Q1 2024 May 15, 2024	SELL	$2.1 - $4.83 $4,191 - $9,640	-1,996 Reduced 32.72%	4,104 $17,000
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $2,234 - $7,441	-1,995 Reduced 24.64%	6,100 $18,000
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $32,275 - $70,634	-26,455 Reduced 76.57%	8,095 $11,000
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $64,272 - $82,038	26,127 Added 310.19%	34,550 $86,000
Q1 2023 May 09, 2023	BUY	$2.57 - $8.16 $244 - $775	95 Added 1.14%	8,423 $23,000
Q4 2022 Feb 10, 2023	SELL	$5.19 - $13.5 $47,104 - $122,526	-9,076 Reduced 52.15%	8,328 $46,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $16.99 $76,123 - $250,160	14,724 Added 549.4%	17,404 $217,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $40,012 - $84,283	-9,904 Reduced 78.7%	2,680 $13,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $91,929 - $133,297	-12,096 Reduced 49.01%	12,584 $95,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $127,660 - $203,176	12,565 Added 103.71%	24,680 $252,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $19,871 - $33,929	-1,510 Reduced 11.08%	12,115 $163,000
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $234,076 - $314,813	11,961 Added 718.81%	13,625 $299,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $152,524 - $282,750	-8,676 Reduced 83.91%	1,664 $40,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $59,928 - $111,241	5,453 Added 111.58%	10,340 $186,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $381 - $783	33 Added 0.68%	4,887 $57,000
Q2 2020 Aug 13, 2020	BUY	$9.57 - $24.37 $26,547 - $67,602	2,774 Added 133.37%	4,854 $118,000
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $18,865 - $54,745	2,080 New	2,080 $23,000
Q4 2019 Feb 07, 2020	SELL	$20.54 - $31.0 $3,491 - $5,270	-170 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$22.78 - $40.58 $3,872 - $6,898	170 New	170 $4,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $1,320 - $4,106	-80 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $3,452 - $5,437	80 New	80 $4,000
Q4 2017 Feb 09, 2018	SELL	$19.01 - $26.2 $21,975 - $30,287	-1,156 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $14,484 - $31,350	1,156	1,156 $29,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account